AbCellera Biologics Inc.
ABCL
Rank in Stocks
#4083
AbCellera Biologics Inc. specializes in pioneering an advanced platform for the... AbCellera Biologics Inc. specializes in pioneering an advanced platform for the discovery of antibodies. This comprehensive, AI-driven system meticulously explores and analyzes natural immune systems to identify antibodies suitable for the creation of new pharmaceutical drugs. As of December 31, 2021, the company had cultivated 156 discovery programs, ranging from completed to in-progress or under contract, in partnership with 36 entities. Notably, AbCellera maintains a crucial research collaboration and license agreement with Eli Lilly and Company. Founded in 2012, the firm is headquartered in Vancouver, Canada.
Share Price
$12.29
Market Cap
$3.98B
Change (1 day)
4.95%
Change (1 year)
120.25%
Country
CA
Trade AbCellera Biologics Inc. (ABCL)
Category
Healthcare
Stock price history for AbCellera Biologics Inc. (ABCL)
Highest end of day price: $12.67 on 2026-10-01
Lowest end of day price: $45.73 on 2020-12-01
Lowest end of day price: $45.73 on 2020-12-01
Stock price history of AbCellera Biologics Inc. from 2020 to 2026
Annual Stock Price Performance
| Year | Performance |
|---|---|
| 2026 (TTM) | 69.39% |
| 2025 | 23.13% |
| 2024 | -44.83% |
| 2023 | -50.84% |
| 2022 | -25.40% |
| 2021 | -68.67% |
| 2020 | 0.00% |
Stock price for similar companies or competitors
| Company | Stock price | Change 1y% | Country |
|---|---|---|---|
| $527.18 | 23.67% |
US
|
|
| $251.29 | 814.11% |
US
|
|
| $138.33 | -3.31% |
AU
|
|
| $890.85 | 6.72% |
NL
|
|
| $752.87 | 7.40% |
CH
|
